The relation between Hormonal disturbances, Liver enzymes and Body Mass Index in Selected Cases of Polycystic Ovarian Syndrome in Iraqis Women

Author : Enas A. Abdulrasul Khazali, Najat Sadeq Hasan, Hadeel Sameer Abd alwahab and Intissar Kadhum Ali

Polycystic Ovarian Syndrome (PCOS) is a common disorder affecting up to 21% of women of childbearing age, thought to be primarily a reproductive disorder. Objective: To evaluate free testosterone, glucose. Total cholesterol, triglyceride, liver enzymes, thyroid hormones and prolactin in overweight PCOS Iraqi women compared with healthy lean women as a control group. Materials and Methods: This was a case-control study carried in Al-Imamaien Al-Kathumain hospital, Baghdad, Iraq; between June 2014 and December 2015. The study included 75 female patients suffering from PCOS. The age of involved patients was 22 - 44 years (32.610 5.696 years). Control group was consisted of 30 healthy volunteer females, whose mean ages were matched (30.140 5.198 years). Results: Our data showed that PCOS overweight women with general clinical signs of hyperandrogenism tended to have a higher BMI than healthy lean women 26.8 4.6 (kg/m2) P <0.05, and total testosterone showed significant elevation 2.080.68 (nmol/L) P ‎<0.05. Our data showed there were a significant increase in mean SD of serum level of glucose 95.00 12.7(mg/dl) , total cholesterol‎ 187.0 50‎ (mg/dl), triglyceride 79.5 30.5(mg/dl) p<0.001 respectively, AST ‎19.14 8.5(U/L), ALT‎ 16.22 4.5‎ (U/L) p<0.05 , TSH 3.4 1.2 μIU/ml, T4 9.5 2.5μg/dl, T3 2.6 0.8 ng/ml p <0.01 and prolactin‎ 27.00 4.5 ng/ml p<0.001 in women with polycystic ovarian syndrome compared with healthy women. Discussion: In adult women with hirsutism and PCOS, obesity is associated with increased total testosterone and decreased SHBG, which results in significantly elevated free and bioavailable testosterone. Conclusion: The greater the BMI the more frequent the presence of steatosis, most of obese women had nonalcoholic fatty liver disease (NAFLD).

Full Text Attachment

Creative Commons License World Journal of Pharmaceutical Science is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at Permissions beyond the scope of this license may be available at